Dr. Kiminobu Sugaya

Professor
University of Central Florida, Florida

Highest Degree
PostDoc Fellow in Pharmacology from Mayo Clinic Jacksonville, USA

My URL
https://livedna.org/81.20404

Share this Profile

Area of Interest:

Pharmacology and Toxicology
Neuropharmacology
Molecular Biology
Neurobiology
Stem Cell

Selected Publications

  1. Mulberry, G., K.A. White, M. Vaidya, K. Sugaya and B.N. Kim, 2017. 3D printing and milling a real- time PCR device for infectious disease diagnostics. PLoS One, Vol. 12. 10.1371/journal.pone.0179133.
    CrossRef  |  

  2. Constant, C., A. Bergano, K. Sugaya and A. Dogariu, 2017. Guiding cellular activity with polarized light. J. Biophotonics. 10.1002/jbio.201600326.
    CrossRef  |  Direct Link  |  

  3. Khorgami, Z. and K. Sugaya, 2015. Sleep pattern: Preventing factors for Alzheimer disease. Br. J. Med. Med. Res., 9: 1-12.

  4. Gaut, C. and K. Sugaya, 2015. Critical review on the physical and mechanical factors involved in tissue engineering of cartilage. Regen. Med., 10: 665-679.
    CrossRef  |  Direct Link  |  

  5. Alvarez, A.A., M. Field, S. Bushnev, M.S. Longo and K. Sugaya, 2015. The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells. J. Mol. Neurosci., 55: 7-20.
    CrossRef  |  Direct Link  |  

  6. Valerio, L.S.A. and K. Sugaya, 2014. Potential therapeutic approaches for stroke using induced pluripotent stem cells. Austin J. Biomed. Eng., 1: 10-16.

  7. Kwak, Y.D., B.J. Hendrix and K. Sugaya, 2014. Secreted type of amyloid precursor protein induces glial differentiation by stimulating the BMP/Smad signaling pathway. Biochem. Biophys. Res. Commun., 447: 394-399.
    CrossRef  |  Direct Link  |  

  8. Kimmel, J. and K. Sugaya, 2014. Nanog overexpression increases neural marker expression in adipose derived stem cells. Recent Patent Regen. Med., 4: 69-74.
    Direct Link  |  

  9. Hendrix, B.J. and K. Sugaya, 2014. The future of neuroregenerative therapy for Parkinson’s disease. Curr. Tissue Eng., 3: 25-33.
    Direct Link  |  

  10. Sugaya, K., 2013. Anti-inflammatory therapy for alzheimer’s disease from epidemiological fact to new mechanisms of action. Anti-Inflammatory Anti-Allergy Agents Med. Chem., 9: 189-196.
    Direct Link  |  

  11. Sugaya, K., R.B. Timmons and T. Patch, 2012. Use of peripheral blood stem cells in tissue engineering. Curr. Tissue Eng., 1: 63-74.
    Direct Link  |  

  12. Sugaya, K., M.B. Youdim, A. Nordberg and K.S. Rao, 2012. Neuroprotection and neuroregeneration in Alzheimer's disease. Int. J. Alzheimers Dis., Vol. 2012. 10.1155/2012/864138.
    CrossRef  |  Direct Link  |  

  13. Keilani, S., D. Healey and K. Sugaya, 2012. Reelin regulates differentiation of neural stem cells by activation of notch signaling through Disabled-1 tyrosine phosphorylation. Can. J. Physiol. Pharmacol., 90: 361-369.
    CrossRef  |  Direct Link  |  

  14. Kwak, Y.D., E. Dantuma, S. Merchant, S. Bushnev and K. Sugaya, 2011. Amyloid-β precursor protein induces glial differentiation of neural progenitor cells by activation of the IL-6/gp130 signaling pathway. Neurotoxicity Res., 18: 328-338.
    CrossRef  |  Direct Link  |  

  15. Kwak, Y.D., A. Marutle, E. Dantuma, S. Merchant, S. Bushnev and K. Sugaya, 2011. Involvement of notch signaling pathway in amyloid precursor protein induced glial differentiation. Eur. J. Pharmacol., 650: 18-27.
    CrossRef  |  Direct Link  |  

  16. Hossain, F. and K. Sugaya, 2011. DNA Demethylation of Human Mesenchymal Stem Cells Has Increased Potential to Become Neuronal Cells. In: Human Mesenchymal and Embryonic Stem Cells, Koka, P.S. (Ed.). Nova Science Publishers, USA., ISBN: 978-1-62081-909-8, pp: 97-108.

  17. Sugaya, K., 2010. Stem cell biology in the study of pathological conditions. Neurodegenerative Dis., 7: 84-87.
    CrossRef  |  Direct Link  |  

  18. Merchant, S., E. Dantuma and K. Sugaya, 2010. A heterocyclic pyrrolopyrimidine compound as a possible candidate for topical application to induce hair restoration. Adv. Stud. Biol., 2: 63-71.

  19. Field, M., A. Alvarez, S. Bushnev and K. Sugaya, 2010. Embryonic stem cell markers distinguishing cancer stem cells from normal human neuronal stem cell populations in malignant glioma patients. Clin. Neurosurg., 57: 151-159.

  20. Dantuma, E., S. Merchant and K. Sugaya, 2010. Stem cells for the treatment of neurodegenerative diseases. Stem Cell Res. Ther., Vol. 1. 10.1186/scrt37.
    CrossRef  |  Direct Link  |  

  21. Chigurupati, S., R. Venkataraman, D. Barrera, A. Naganathan and M. Madan et al., 2010. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. Cancer Res., 70: 418-427.

  22. Alvarez, A., M. Hossain, E. Dantuma, S. Merchant and K. Sugaya, 2010. Nanog overexpression allows human mesenchymal stem cells to differentiate into neural cells-Nanog transdifferentiates mesenchymal stem cells. Neurosci. Med., 1: 1-13.
    CrossRef  |  Direct Link  |  

  23. Vrotsos, E.G., P.E. Kolattukudy and K. Sugaya, 2009. MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling. Brain Res. Bull., 79: 97-103.
    CrossRef  |  Direct Link  |  

  24. Vrotsos, E.G. and K. Sugaya, 2009. MCP-1-induced migration of NT2 neuroprogenitor cells involving APP signaling. Cell Mol. Neurobiol., 29: 373-381.
    CrossRef  |  Direct Link  |  

  25. Field, M., S. Bushnev, A.A. Alvarez, N. Avgeropoulos and K. Sugaya, 2009. Markers distinguishing cancer stem cells from normal human neuronal stem cell populations in malignant glioma patients. Neurosurgery, 65: 426-426.

  26. Biener, G., E. Vrotsos, K. Sugaya and A. Dogariu, 2009. Optical torques guiding cell motility. Opt. Express, 17: 9724-9732.

  27. Sugaya, K., 2008. Mechanism of glial differentiation of neural progenitor cells by amyloid precursor protein. Neurodegenerative Dis., 5: 170-172.
    CrossRef  |  Direct Link  |  

  28. Sugaya, K. and S. Merchant, 2008. How to approach Alzheimer's disease therapy using stem cell technologies. J. Alzheimers Dis., 15: 241-254.
    CrossRef  |  Direct Link  |  

  29. Liu, D., K.A. Hua and K. Sugaya, 2008. A generic framework for internet-based interactive applications of high-resolution 3-D medical image data. IEEE Trans. Inform. Technol. Biomed., 12: 618-626.

  30. Keilani, S. and K. Sugaya, 2008. Reelin induces a radial glial phenotype in human neural progenitor cells by activation of Notch-1. BMC Dev. Biol., Vol. 8. 10.1186/1471-213X-8-69.
    CrossRef  |  Direct Link  |  

  31. Hossain, F. and K. Sugaya, 2008. DNA demethylation of human mesenchymal stem cells has increased potential of become neuronal cells. J. Stem Cells, 3: 173-182.

  32. Sugaya, K., Y.D. Kwak, O. Ohmitsu, A. Marutle, N.H. Greig and E. Choumrina, 2007. Practical issues in stem cell therapy for Alzheimer's disease. Curr. Alzheimer Res., 4: 370-377.

  33. Pulido, J.S., I. Sugaya, J. Comstock and K. Sugaya, 2007. Reelin expression is upregulated following ocular tissue injury. Graefes Arch. Clin. Exp. Ophthalmol., 245: 889-893.
    CrossRef  |  Direct Link  |  

  34. Marutle, A., M. Ohmitsu, N. Nilbratt, N.H. Greig, A. Nordberg and K. Sugaya, 2007. Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine. Proc. Natl. Acad. Sci. USA., 104: 12506-12511.
    CrossRef  |  Direct Link  |  

  35. Sugaya, K., A. Alvarez, A. Marutle and Y.D. Kwak, 2006. Choumkina E: Stem cell strategies for Alzheimer's disease therapy. Panminerva Med., 48: 87-96.

  36. Sugaya, I., T. Qu, K. Sugaya and G.D. Pappas, 2006. Genetically enginieered human mesenchymal stem cells produce Met-Enkephalin at augmented higher levels in vitro. Cell Transplant., 15: 225-230.

  37. Roitberg, B.Z., E. Mangubat, E.Y. Chen, K. Sugaya and K.R. Thulborn et al., 2006. Survival and early differentiation of human neural stem cells transplanted in a nonhuman primate model of stroke. J. Neurosurg., 105: 96-102.
    CrossRef  |  Direct Link  |  

  38. Kwak, Y.D., E. Choumkina and K. Sugaya, 2006. Amyloid precursor protein is involved in staurosporine induced glial differentiation of neural progenitor cells. Biochem. Biophys. Res. Commun., 344: 431-437.
    CrossRef  |  Direct Link  |  

  39. Kwak, Y.D., C.L. Brannen, T. Qu, H.M. Kim and X. Dong et al., 2006. Amyloid precursor protein regulates differentiation of human neural stem cells. Stem Cells Dev., 15: 381-389.
    CrossRef  |  Direct Link  |  

  40. Kwak, Y.D. and K. Sugaya, 2006. RNA interference in human NTera-2/D1 cell lines using human U6 promoter-based siRNA PCR products. Biotechnol. Bioprocess Eng., 3: 273-276.

  41. Sugaya, K., 2005. Stem Cell Strategies for Alzheimer’s Disease. In: Recent Progress in Alzheimer’s and Parkinson’s Diseases, Hanin, I., R. Cacabelos and A. Fisher (Eds.). Taylor and Francis Inc., New York, pp: 183-190.

  42. Sugaya, K., 2005. Possible use of autologous stem cell therapies for Alzheimer`s disease. Curr. Alzheimer Res., 2: 367-376.

  43. Qu, T., X. Dong, I. Sugaya, A. Vaghani, J. Pulido and K. Sugaya, 2004. Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells. Restor. Neurol. Neurosci., 22: 459-468.

  44. Sugaya, K., 2003. Stem cell strategies, future and beyond. Seishin Shinkeikagaku Zasshi, 105: 68-80.

  45. Sugaya, K., 2003. Stem cell biology under pathological condition. J. Cell. Mol. Life Sci., 60: 1891-1902.

  46. Sugaya, K., 2003. Stem Cell Therapy for Alzheimer’s Disease. In: Alzheimer's Disease-The Basics: A Physician's Guide to the Practical Management, Richter, R.W. and B. Richter (Eds.). Humana Press, New York, pp: 289-300.

  47. Sugaya, K., 2003. Research strategy for understanding neuronal plasticity and degeneration. Psychiatrica et Neurologica Japonica, 105: 43-46.

  48. Sugaya, K., 2003. Potential use of stem cells in neuroreplacement therapies for neurodegenerative disease. Int. Rev. Cytol., 228: 1-23.

  49. Sugaya, K., 2003. Neurodevelopment hypothesis of schizophrenia and genes. Schizophrenia Front., 4: 32-36.

  50. Sugaya, K., 2003. Current topics in stem cell research. Pharmacia, 39: 103-107.

  51. Kwak, Y.D., H. Koike and K. Sugaya, 2003. RNA interference with small hairpin RNAs transcribed from a human U6 promoter-driven DNA vector. J. Pharmacol. Sci., 93: 214-217.
    CrossRef  |  Direct Link  |  

  52. Dong, X., J. Pulido and K. Sugaya, 2003. Differentiation of human neural stem cells into retinal cells. NeuroReport, 14: 143-146.

  53. Uz, T., T. Qu, K. Sugaya and H. Manev, 2002. Neuronal expression of arylalkylamine N-acetyltransferase (AANAT) mRNA in the rat brain. Neurosci. Res., 42: 309-316.
    CrossRef  |  Direct Link  |  

  54. Sugaya, K., T. Qu, C. Brannen and M. Kim, 2002. Human Neural Stem Cell Transplantation Improves Cognitive Function in Aged Rats. In: Mapping the Progress of Alzheimer’s and Parkinson’s Disease, Mizuno, Y., A. Fisher and I. Hanin (Eds.). Springer, New York, ISBN: 9780306467639, pp: 229-234.

  55. Kim, H.M., T. Qu, V. Kriho, P. Lacor and N. Smalheiser et al., 2002. Reelin function in neural stem cell biology. Proc. Nat. Acad. Sci., 99: 4020-4025.
    CrossRef  |  Direct Link  |  

  56. Sugaya, K., T. Uz, V. Kumar and H. Manev, 2001. New anti-inflammatory treatment strategy in Alzheimer's disease. Japanese J. Pharmacol., 82: 85-94.
    CrossRef  |  

  57. Sugaya, K., 2001. Human neural stem cell transplantation as a future therapy for neurodegenerative disease. Brain Sci., 23: 882-884.

  58. Sugaya, K., 2001. Glial activation in aging and its pathological implication. Folia Pharmacol. Japonica, 118: 251-257.

  59. Sugaya, K. and C.L. Brannen, 2001. Stem cell strategies for neuroreplacement therapy in Alzheimer's disease. Med. Hypotheses, 57: 697-700.
    CrossRef  |  Direct Link  |  

  60. Qu, T., C.L. Brannen, H.M. Kim and K. Sugaya, 2001. Human neural stem cells improve cognitive function of aged brain. Neuroreport, 12: 1127-1132.
    Direct Link  |  

  61. Nicolle, M.M., J. Gonzalez, K. Sugaya, K.A. Baskerville and D. Bryan et al., 2001. Signatures of hippocampal oxidative stress in aged spatial learning-impaired rodents. Neuroscience, 107: 415-431.
    CrossRef  |  Direct Link  |  

  62. Hernandez, D., K. Sugaya, T. Qu, E. McGowan, K. Duff and M. McKinney, 2001. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes. Neuroreport, 12: 1377-1384.
    Direct Link  |  

  63. Manev, H., T. Uz, K. Sugaya and T. Qu, 2000. Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J., 14: 1464-1469.
    CrossRef  |  

  64. Fass, U., K. Panickar, D. Personett, D. Bryan and K. Williams et al., 2000. Differential vulnerability of primary cultured cholinergic neurons to nitric oxide excess. Neuroreport, 11: 931-936.
    Direct Link  |  

  65. Brannen, C.L. and K. Sugaya, 2000. In vitro differentiation of multipotent human neural progenitors in serum‐free medium. Neuroreport, 11: 1123-1128.

  66. Kent, C., K. Sugaya, D. Bryan, D. Personett and M. McKinney, 1999. Expression of superoxide dismutase messenger RNA in adult rat brain cholinergic neurons. J. Mol. Neurosci., 12: 1-10.
    Direct Link  |  

  67. Sugaya, K., S. Chou, S.J. Xu and M. McKinney, 1998. Indicators of glial activation and brain oxidative stress after intraventricular infusion of endotoxin. Mol. Brain Res., 58: 1-9.
    CrossRef  |  Direct Link  |  

  68. Sugaya, K., R. Greene, D. Personett, M. Robbins and C. Kent et al., 1998. Septo-hippocampal cholinergic and neurotrophin markers in age-induced cognitive decline. Neurobiol. Aging, 19: 351-361.
    CrossRef  |  Direct Link  |  

  69. Sugaya, K., M.L. Chouinard and M. McKinney, 1997. Induction of manganese superoxide dismutase in BV-2 microglial cells. Neuroreport, 8: 3547-3551.
    Direct Link  |  

  70. Sugaya, K., M. Reeves and M. McKinney, 1997. Topographic associations between DNA fragmentation and Alzheimer`s disease neuropathology in the hippocampus. Neurochem. Int., 31: 275-281.
    CrossRef  |  

  71. Sugaya, K., M. Chouinard and M. McKinney, 1997. Immunostimulation protects microglial cells from nitric oxide-mediated apoptosis. Neuroreport, 8: 2241-2245.
    Direct Link  |  

  72. Sugaya, K., C. Clamp, D. Bryan and M. McKinney, 1997. Messenger RNA for the m4 muscarinic receptor subtype is expressed in adult rat central cholinergic neurons. Mol. Brain Res., 50: 305-313.

  73. Personett, D., K. Sugaya, D. Hammond, M. Robbins and M. McKinney, 1997. Use of capillary electrophoresis with laser‐induced fluorescence detection to assess messenger ribonucleic acid molecules amplified by the polymerase chain reaction: Applications in the cloning of cells. Electrophoresis, 18: 1750-1759.
    CrossRef  |  Direct Link  |  

  74. Sugaya, K., M. Chouinard, R. Greene, M. Robbins and D. Personett et al., 1996. Molecular indices of neuronal and glial plasticity in the hippocampal formation in a rodent model of age-induced spatial learning impairment. J. Neurosci., 16: 3427-3443.
    Direct Link  |  

  75. Personett, D.A., M. Chouinard, K. Sugaya and M. McKinney, 1996. Simplified RT/PCR quantitation of gene transcripts in cultured neuroblastoma (SN49) and microglial (BV-2) cells using capillary electrophoresis and laser-induced fluorescence. J. Neurosci. Methods, 65: 77-91.
    CrossRef  |  

  76. Kumar, V., K. Sugaya, S. Saunders and J. Mechanic, 1996. Update on cholinergic drugs in Alzheimer's disease. Medicamentos de Actualidad, 32: 529-537.

  77. Sugaya, K., K. Matsunaga, Y. Sei and M. McKinney, 1995. Kangenkaryu, Chinese Herb Medicine, Improved Several Symptoms in the Animal Model. In: Alzheimer's and Parkinson's Diseases: Recent Advances, Hanin, I., A. Fisher and M. Yoshida (Eds.). Plenum Publishing Corporation, USA., pp: 411-419.

  78. Sugaya, K. and M. McKinney, 1994. Nitric oxide synthase gene expression in cholinergic neurons in the rat brain examined by combined immunocytochemistry and in situ hybridization histochemistry. Brain Res. Mol., 23: 111-125.
    CrossRef  |  

  79. Sugaya, K. and M. McKinney, 1994. Nitric Oxide Synthase in a Lesion Model of Alzheimer's Disease. In: Current Research in Alzheimer Therapy, Giacobini, E. and R. Becker (Eds.). Taylor and Francis, New York, pp: 304-309.

  80. Kizuki, K., T. Suzuki, K. Sugaya, T. Noguchi and M. Kudo, 1994. Tissue kallikrein in rat and mouse neurons. Braz. J. Med. Biol. Res., 27: 1891-1896.
    Direct Link  |  

  81. Takahashi, M., K. Sugaya, K. Kojima, T. Katoh, M. Ueki and K. Kubota, 1993. SUT-8701, a cholecystokinin analog, prevents the cholinergic degeneration in the rat cerebral cortex following basal forebrain lesioning. Japanese J. Pharmacol., 61: 341-349.
    CrossRef  |  

  82. Takahashi, M., K. Sugaya and K. Kubota, 1992. Kangenkaryu prevents the decrease of cholinergic markers following the nucleus basalis magnocellularis lesion. Japanese J. Pharmacol., 60: 307-310.
    CrossRef  |  

  83. Sugaya, K., M. Takahashi and K. Kubota, 1992. Cholecystokinin protects cholinergic neurons against basal forebrain lesion. Japanese J. Pharmacol., 59: 125-128.
    CrossRef  |  

  84. Sugaya, K., M. Downen and E. Giacobini, 1991. Nucleus basalis lesion decrease bungarotoxins binding site in rat cortex. Neuro Rep., 2: 177-180.

  85. Sugaya, K., 1991. The Effect of Kangenkaryu on the Dementia Model Animal. In: Ecology in Food, Igarashi, N. and K. Namiki (Eds.). Happy End Book, Tokyo, Japan, pp: 97-102.

  86. Sugaya, K., E. Giacobini and V.A. Chiappinelli, 1990. Nicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease. J. Neurosci. Res., 27: 349-359.
    CrossRef  |  Direct Link  |  

  87. Giacobini, E., R.J. Elble and K. Sugaya, 1990. Markers of Cholinergic Dysfunction in Alzheimer Disease. In: Alzheimer Disease Current Research in Early Diagnosis, Becker, R.E. and E. Giacobini (Eds.). Taylor and Francis, New York, pp: 137-156.

  88. Tang, Z.C., P. DeSarno, K. Sugaya and E. Giacobini, 1989. The effect of huperzin-A, new cholinesterase inhibitor, of the central cholinergic system of the rat. J. Neurosci. Res., 24: 276-285.

  89. Kubota, K., K. Sugaya, Y. Koizumi and M. Toda, 1989. Cholecystokinin antagonism by anthramycin, a benzodiazepine antibiotic, in the central nervous system in mice. Brain Res., 485: 62-66.
    CrossRef  |  Direct Link  |  

  90. Downen, M., K. Sugaya, S.P. Arneric and E. Giacobini, 1989. Time Course of Alteration ACh Synthesis and Release and Alpha-Bungarotoxin Binding in Rat Cortex Following Ibotenic Acid Lesion of the Basal Forebrain. In: Novel Approaches to the Treatment of Alzheimer's Disease, Meyer, E.M., J.W. Impkins and J. Yamamoto (Eds.). Plenum Press, New York, pp: 255-268.

  91. Sugaya, K., M.O. Maimets and K. Kubota, 1988. 2-deoxy-D-(14C)-glucose study of the interaction of caerulein and apomorphine. Japanese J. Pharmacol., 48: 131-136.
    CrossRef  |  

  92. Sugaya, K. and K. Kubota, 1988. Autoradiographic demonstration of the antagonism of anthramycin and diazepam against cholecystokinin in the mouse brain using the [14C]-2-deoxyglucose method. Japanese J. Pharmacol., 48: 1-6.
    CrossRef  |  

  93. Kubota, K., K. Sugaya and K. Hotta, 1988. Effects of cimetidine on prostanoid production in the gastric corpus specimens from rats. Japanese J. Pharmacol., 48: 491-493.

  94. Sugaya, K., I. Matsuda and K. Kubota, 1987. Possible involvement of the CCK receptor in the benzodiazepine antagonism to CCK in the mouse brain. Japanese J. Pharmacol., 43: 67-71.
    CrossRef  |  

  95. Kubota, K., I. Matsuda, K. Sugaya and T. Uruno, 1986. Cholecystokinin antagonism by benzodiazepines in the food intake in mice. Physiol. Behav., 36: 175-178.
    CrossRef  |  Direct Link  |  

  96. Kubota, K., F. Sun, K. Sugaya and N. Sunagane, 1986. Reversal of antinociceptive effect of caerulein by benzodiazepine. J. Pharm. Dynamics, 9: 428-431.
    CrossRef  |  

  97. Sugaya, K., I. Matsuda and K. Kubota, 1985. Inhibition of hypothermic effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788, in mice. Japanese J. Pharmacol., 39: 277-280.
    CrossRef  |  

  98. Kubota, K., K. Sugaya, N. Sunagane, I. Matsuda and T. Uruno, 1985. Cholecystokinin antagonism by benzodiazepines in the contractile response of the isolated guinea-pig gallbladder. Eur. J. Pharmacol., 110: 225-231.
    CrossRef  |  Direct Link  |  

  99. Kubota, K., K. Sugaya, I. Matsuda, Y. Matsuoka and Y. Terawaki, 1985. Reversal of antinociceptive effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788. Japanese J. Pharmacol., 37: 101-105.
    CrossRef  |  

  100. Kubota, K., K. Sugaya, I. Matsuda, Y. Matsuoka and M. Itonaga, 1985. Caerulein antagonism by benzodiazepines in the food intake in mice. Japanese J. Pharmacol., 39: 120-122.
    CrossRef  |  

  101. Kubota, K., K. Sugaya, F. Fujii, M. Itonaga and N. Sunagane, 1985. Inhibition of cholecystokinin response in the gallbladder by dibenamine and its protection by benzodiazepines. Japanese J. Pharmacol., 39: 274-276.
    CrossRef  |  
Member since October, 2017